Phase I/Ii study of combination high-dose therapy with busulfan, thiotepa, and total body irradiation (TBI) for the treatment of aggressive multiple myeloma
Jose F. Leis, Keith S. Hansen, Mark W. Brunvand, William H. Fleming
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Phase I/Ii study of combination high-dose therapy with busulfan, thiotepa, and total body irradiation (TBI) for the treatment of aggressive multiple myeloma'. Together they form a unique fingerprint.